Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Hauser

This article was originally published in The Tan Sheet

Executive Summary

Supplement company merging certain business operations with Zuellig Botanical Extracts in a deal worth $66 mil., the companies announce Dec. 9. In addition to Zuellig, the deal includes Wilcox Drug (Wilcox Natural Products) and ZetaPharm, and creates what the companies call the "leading U.S. supplier of herbal extracts, botanical raw materials and related products." Long Beach, Calif.-based Zuellig markets and distributes herbal extracts and other products, Wilcox cultivates and sources wild-crafted botanical raw materials and ZetaPharm "imports and distributes bulk vitamins, nutritional supplements, pharmaceutical ingredients and food additives." To "focus corporate resources...Hauser will discontinue its paclitaxel business and at the end of the current fiscal quarter will incur a one-time charge of approximately $25 mil.-$30 mil.," the companies note

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS089212

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel